Characterization of a polyclonal cytolytic T lymphocyte response to human immunodeficiency virus in persons without clinical progression

Journal of Infectious Diseases

Volumn 175, Issue 6, 1997, Pages 1360-1367

  Lubaki, N M ^b   Ray, S C ^b   Dhruva, B ^b   Quinn, T C ^b   Siliciano, R F ^b   Bollinger, R C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; GENE REARRANGEMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE CLONE; MALE; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; VIRUS DETECTION;

EID: 0030918617     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/516468     Document Type: Article

References (12)

1. Walker BD, Chakarabarti S, Moss B, et al. HIV-specific cytotoxic T-lymphocytes in seropositive individuals. Nature 1987;382:345-8.
2. + human cytolytic T cells specific for HIV-infected cells by a gp160 subunit vaccine. Science 1990;248:1234-7.
3. Hammond SA, Obah E, Stanhope P, et al. Characterization of a conserved T cell epitope in H1V-l gp4l recognized by vaccine-induced human cytolytic T cells. J Immunol 1991; 146:1470-7.
4. Egan MA, Pavlat WA, Tartaglia J, et al. Induction of human immunodeficiency virus type 1 (HIV-l)-specific cytolytic T lymphocyte responses in seronegative adults by a nonreplicating, host-range-restricted canarypox vector (ALVAC) carrying the HIV-1 MN env gene. J Infect Dis 1995; 171:1623-7.
5. + cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-l vaccines. J Exp Med 1992; 176:1531-42.
6. Lubaki MN, Egan MA, Siliciano RF, Weinhold KJ, Bollinger RC. A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes. AIDS Res Hum Retroviruses 1994; 10:1427-31.
7. Carmichael A, Jin X, Sissons P, Borysiewicz L. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-l)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med 1993; 177:249-56.
8. Grant MD, Smaill FM, Singal DP, Rosenthal KL. The influence of lymphocyte counts and disease progression on circulating and inducible anti-HIV-1 cytotoxic T-cell activity in HIV-1 -infected subjects. AIDS 1992; 6:1085-94.
9. Rinaldo C, Huang XL, Fan ZF, et al. High levels of anti-human immuno-deficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J Virol 1995;69:5838-42.
10. - T cell population. J Immunol 1990; 144:1696-704.
11. Venet A, Walker BD. Cytotoxic T-cell epitopes in HIV/SIV infection. AIDS 1993;7(suppl l):S117-26.
12. Nixon DF, McMichael AJ. Cytotoxic T-cell recognition of HIV proteins and peptides. AIDS 1991;5:1049-59.